LRpath analysis reveals common pathways dysregulated via DNA methylation across cancer types

BMC Genomics

Volumn 13, Issue 1, 2012, Pages

  Kim, Jung H ^a,b   Karnovsky, Alla ^a   Mahavisno, Vasudeva ^a   Weymouth, Terry ^a   Pande, Manjusha ^a   Dolinoy, Dana C ^b   Rozek, Laura S ^a,b   Sartor, Maureen A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDASE; VOLTAGE GATED POTASSIUM CHANNEL;

ARTICLE; CANCER CLASSIFICATION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MATURATION; COMPUTER PROGRAM; DNA METHYLATION; DNA REPAIR; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; EPIDERMIS; IMMUNE RESPONSE; INTERNET; KERATINOCYTE; NEOPLASM; NERVOUS SYSTEM DEVELOPMENT;

CLUSTER ANALYSIS; CPG ISLANDS; DNA METHYLATION; HUMANS; INTERNET; KV1.3 POTASSIUM CHANNEL; NEOPLASMS; PROMOTER REGIONS, GENETIC; SOFTWARE; USER-COMPUTER INTERFACE;

EID: 84866908944     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-13-526     Document Type: Article

References (53)

1. Sartor MA, Mahavisno V, Keshamouni VG, Cavalcoli J, Wright Z, Karnovsky A, Kuick R, Jagadish HV, Mirel B, Weymouth T, et al. ConceptGen: a gene set enrichment and gene set relation mapping tool. Bioinformatics 2010, 26:456-463. 10.1093/bioinformatics/btp683, 2852214, 20007254.
2. Furney SJ, Gundem G, Lopez-Bigas N. Oncogenomics methods and resources. Cold Spring Harb Protoc 2012 May 1, 2012(5). pii: pdb.top069229.
3. Shaknovich R, Geng H, Johnson NA, Tsikitas L, Cerchietti L, Greally JM, Gascoyne RD, Elemento O, Melnick A. DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma. Blood 2010, 116:e81-e89. 10.1182/blood-2010-05-285320, 2993635, 20610814.
4. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4:P3. 10.1186/gb-2003-4-5-p3, 12734009.
5. Hosack DA, Dennis G, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol 2003, 4:R70. 10.1186/gb-2003-4-10-r70, 328459, 14519205.
6. Draghici S, Khatri P, Bhavsar P, Shah A, Krawetz SA, Tainsky MA. Onto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate. Nucleic Acids Res 2003, 31:3775-3781. 10.1093/nar/gkg624, 169030, 12824416.
7. Khatri P, Sellamuthu S, Malhotra P, Amin K, Done A, Draghici S. Recent additions and improvements to the Onto-Tools. Nucleic Acids Res 2005, 33:W762-W765. 10.1093/nar/gki472, 1160233, 15980579.
8. Carey VJ, Gentry J, Whalen E, Gentleman R. Network structures and algorithms in Bioconductor. Bioinformatics 2005, 21:135-136. 10.1093/bioinformatics/bth458, 15297301.
9. Zeeberg BR, Feng W, Wang G, Wang MD, Fojo AT, Sunshine M, Narasimhan S, Kane DW, Reinhold WC, Lababidi S, et al. GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol 2003, 4:R28. 10.1186/gb-2003-4-4-r28, 154579, 12702209.
10. Zeeberg BR, Qin H, Narasimhan S, Sunshine M, Cao H, Kane DW, Reimers M, Stephens RM, Bryant D, Burt SK, et al. High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID). BMC Bioinformatics 2005, 6:168. 10.1186/1471-2105-6-168, 1190154, 15998470.
11. Berriz GF, King OD, Bryant B, Sander C, Roth FP. Characterizing gene sets with FuncAssociate. Bioinformatics 2003, 19:2502-2504. 10.1093/bioinformatics/btg363, 14668247.
12. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005, 102:15545-15550. 10.1073/pnas.0506580102, 1239896, 16199517.
13. Sartor MA, Leikauf GD, Medvedovic M. LRpath: a logistic regression approach for identifying enriched biological groups in gene expression data. Bioinformatics 2009, 25:211-217. 10.1093/bioinformatics/btn592, 2639007, 19038984.
14. Newton MA, Quintana FA, den Boon JA, Sengupta S, Ahlquist P. Random-set methods identify distinct aspects of the enrichment signal in gene-set analysis. Ann Appl Stat 2007, 1:85-106.
15. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002, 3:415-428.
16. Coleman WB, Rivenbark AG. Quantitative DNA methylation analysis: the promise of high-throughput epigenomic diagnostic testing in human neoplastic disease. J Mol Diagn: JMD 2006, 8:152-156. 10.2353/jmoldx.2006.060026, 1867580, 16645200.
17. Yegnasubramanian S, Haffner MC, Zhang Y, Gurel B, Cornish TC, Wu Z, Irizarry RA, Morgan J, Hicks J, DeWeese TL, et al. DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity. Cancer Res 2008, 68:8954-8967. 10.1158/0008-5472.CAN-07-6088, 2577392, 18974140.
18. Cho NY, Kim BH, Choi M, Yoo EJ, Moon KC, Cho YM, Kim D, Kang GH. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features. J Pathol 2007, 211:269-277. 10.1002/path.2106, 17139617.
19. De S, Michor F. DNA secondary structures and epigenetic determinants of cancer genome evolution. Nat Struct Mol Biol 2011, 18:950-955. 10.1038/nsmb.2089, 21725294.
20. Rubin MA, De Marzo AM. Molecular genetics of human prostate cancer. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc 2004, 17:380-388.
21. Wilson AS, Power BE, Molloy PL. DNA hypomethylation and human diseases. Biochim Biophys Acta 2007, 1775:138-162.
22. Esteller M, Herman JG. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 2002, 196:1-7. 10.1002/path.1024, 11748635.
23. Cruz-Correa M, Cui H, Giardiello FM, Powe NR, Hylind L, Robinson A, Hutcheon DF, Kafonek DR, Brandenburg S, Wu Y, et al. Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition. Gastroenterology 2004, 126:964-970. 10.1053/j.gastro.2003.12.051, 15057734.
24. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004, 4:143-153. 10.1038/nrc1279, 14732866.
25. Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, Lee TI, Levine SS, Wernig M, Tajonar A, Ray MK, et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 2006, 441:349-353. 10.1038/nature04733, 16625203.
26. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet: TIG 2000, 16:168-174. 10.1016/S0168-9525(99)01971-X, 10729832.
27. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. 2005, 352:997-1003.
28. Castro A, Bernis C, Vigneron S, Labbe JC, Lorca T. The anaphase-promoting complex: a key factor in the regulation of cell cycle. Oncogene 2005, 24:314-325. 10.1038/sj.onc.1207973, 15678131.
29. Liggett WH. Sidransky D: Role of the p16 tumor suppressor gene in cancer. J Clin Oncol: official journal of the American Society of Clinical Oncology 1998, 16:1197-1206.
30. Lee J, Son MJ, Woolard K, Donin NM, Li A, Cheng CH, Kotliarova S, Kotliarov Y, Walling J, Ahn S, et al. Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell 2008, 13:69-80. 10.1016/j.ccr.2007.12.005, 2835498, 18167341.
31. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444. 10.1038/nature07205, 18650914.
32. Rodenhiser DI. Epigenetic contributions to cancer metastasis. Clin Exp Metastasis 2009, 26:5-18. 10.1007/s10585-008-9166-2, 18386135.
33. Volkmer JP, Sahoo D, Chin RK, Ho PL, Tang C, Kurtova AV, Willingham SB, Pazhanisamy SK, Contreras-Trujillo H, Storm TA, et al. Three differentiation states risk-stratify bladder cancer into distinct subtypes. Proc Natl Acad Sci USA 2012, 109:2078-2083. 10.1073/pnas.1120605109, 3277552, 22308455.
34. Oyama T, Kagawa N, Kunugita N, Kitagawa K, Ogawa M, Yamaguchi T, Suzuki R, Kinaga T, Yashima Y, Ozaki S, et al. Expression of cytochrome P450 in tumor tissues and its association with cancer development. Front Biosci: a journal and virtual library 2004, 9:1967-1976.
35. Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, Marth C, Weisenberger DJ, Campan M, Young J, Jacobs I, Laird PW. Epigenetic stem cell signature in cancer. Nat Genet 2007, 39:157-158. 10.1038/ng1941, 17200673.
36. Fiske JL, Fomin VP, Brown ML, Duncan RL, Sikes RA. Voltage-sensitive ion channels and cancer. Cancer Metastasis Rev 2006, 25:493-500. 10.1007/s10555-006-9017-z, 17111226.
37. Brevet M, Fucks D, Chatelain D, Regimbeau JM, Delcenserie R, Sevestre H, Ouadid-Ahidouch H. Deregulation of 2 potassium channels in pancreas adenocarcinomas: implication of KV1.3 gene promoter methylation. Pancreas 2009, 38:649-654. 10.1097/MPA.0b013e3181a56ebf, 19465885.
38. Brevet M, Haren N, Sevestre H, Merviel P, Ouadid-Ahidouch H. DNA methylation of K(v)1.3 potassium channel gene promoter is associated with poorly differentiated breast adenocarcinoma. Cell Physiol Biochem: international journal of experimental cellular physiology, biochemistry, and pharmacology 2009, 24:25-32.
39. Pillozzi S, Arcangeli A. Physical and functional interaction between integrins and hERG1 channels in cancer cells. Adv Exp Med Biol 2010, 674:55-67. 10.1007/978-1-4419-6066-5_6, 20549940.
40. Cherubini A, Hofmann G, Pillozzi S, Guasti L, Crociani O, Cilia E, Di Stefano P, Degani S, Balzi M, Olivotto M, et al. Human ether-a-go-go-related gene 1 channels are physically linked to beta1 integrins and modulate adhesion-dependent signaling. Mol Biol Cell 2005, 16:2972-2983. 10.1091/mbc.E04-10-0940, 1142440, 15800067.
41. Winter SL, Bosnoyan-Collins L, Pinnaduwage D, Andrulis IL. Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors. Neoplasia 2007, 9:797-800. 10.1593/neo.07595, 2040206, 17971899.
42. Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 2005, 26:1241-1246.
43. Hayashi S, Morishita R, Matsushita H, Nakagami H, Taniyama Y, Nakamura T, Aoki M, Yamamoto K, Higaki J, Ogihara T. Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21. Hypertension 2000, 35:237-243. 10.1161/01.HYP.35.1.237, 10642304.
44. Hannon GJ, Beach D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 1994, 371:257-261. 10.1038/371257a0, 8078588.
45. Mohn F, Schubeler D. Genetics and epigenetics: stability and plasticity during cellular differentiation. Trends Genet: TIG 2009, 25:129-136. 10.1016/j.tig.2008.12.005, 19185382.
46. Gabory A, Attig L, Junien C. Developmental programming and epigenetics. Am J Clin Nutr 2011, 94:1943S-1952S. 10.3945/ajcn.110.000927, 22049164.
47. Saldanha AJ. Java Treeview-extensible visualization of microarray data. Bioinformatics 2004, 20:3246-3248. 10.1093/bioinformatics/bth349, 15180930.
48. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998, 95:14863-14868. 10.1073/pnas.95.25.14863, 24541, 9843981.
49. Kim YH, Lee HC, Kim SY, Yeom YI, Ryu KJ, Min BH, Kim DH, Son HJ, Rhee PL, Kim JJ, et al. Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations. Ann Surg Oncol 2011, 18:2338-2347. 10.1245/s10434-011-1573-y, 3393129, 21298349.
50. Etcheverry A, Aubry M, de Tayrac M, Vauleon E, Boniface R, Guenot F, Saikali S, Hamlat A, Riffaud L, Menei P, et al. DNA methylation in glioblastoma: impact on gene expression and clinical outcome. BMC Genomics 2010, 11:701. 10.1186/1471-2164-11-701, 3018478, 21156036.
51. Walker BA, Wardell CP, Chiecchio L, Smith EM, Boyd KD, Neri A, Davies FE, Ross FM, Morgan GJ. Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma. Blood 2011, 117:553-562. 10.1182/blood-2010-04-279539, 20944071.
52. Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474:609-615. 10.1038/nature10166, 3163504, 21720365.
53. Kobayashi Y, Absher DM, Gulzar ZG, Young SR, McKenney JK, Peehl DM, Brooks JD, Myers RM, Sherlock G. DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer. Genome Res 2011, 21:1017-1027. 10.1101/gr.119487.110, 3129245, 21521786.